WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2005011602) COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/011602 International Application No.: PCT/US2004/024843
Publication Date: 10.02.2005 International Filing Date: 30.07.2004
IPC:
A61K 31/56 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Applicants: ROBINSON, Cynthia, B.[US/US]; US (UsOnly)
BALL, Howard, A.[GB/US]; US (UsOnly)
EPIGENESIS PHARMACEUTICALS LLC[US/US]; 7 Clarke Drive Cranbury, NJ 08512, US (AllExceptUS)
Inventors: ROBINSON, Cynthia, B.; US
BALL, Howard, A.; US
Agent: HALLUIN, Albert, P.; Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto, CA 94306-1050, US
Priority Data:
10/698,07726.10.2003US
60/492,22931.07.2003US
Title (EN) COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
(FR) COMBINAISON DE DEHYDROEPIANDROSTERONE OU DE SULFATE DE DEHYDROEPIANDROSTERONE ET D'UN INHIBITEUR DE PDE-4 POUR LE TRAITEMENT DE L'ASTHME OU D'UNE MALADIE OBSTRUCTIVE RESPIRATOIRE
Abstract:
(EN) A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent comprising a phosphodiesterase-4 inhibitor for the treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.
(FR) La combinaison pharmaceutique ou vétérinaire de l'invention comprend un premier principe actif pris parmi une déhydroépiandrostérone et/ou un sulfate de déhydroépiandrostérone, ou bien un sel de ces substances, et un second principe actif renfermant un inhibiteur de la phosphodiestérase-4 pour le traitement de l'asthme, des maladies obstructive respiratoires et autres pathologies respiratoires. Cette composition se présente en diverses formulations et sous forme d'une trousse. Les produits de cette invention s'utilisent à titre prophylactique et thérapeutique pour l'asthme, les maladies obstructives respiratoires et autres pathologies respiratoires.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)